Renal replacement therapy in acute renal failure

Area of Science:

• Nephrology
• Critical Care Medicine

Background:

• Acute renal failure (ARF) is a prevalent condition in hospitalized patients, distinct from chronic renal failure (CRF).
• Current management approaches for ARF are highly variable and lack standardization.
• The Acute Dialysis Quality Initiative (ADQI) was established to foster consensus and standardize ARF treatment.

Purpose of the Study:

• To review the current landscape of ARF treatment technologies.
• To compare the advantages and disadvantages of different renal replacement therapy modalities.
• To propose a framework for individualized ARF treatment selection.

Main Methods:

• Review of existing literature and treatment modalities for ARF.
• Comparison of intermittent haemodialysis (IHD), continuous renal replacement therapies (CRRT), and slow, low-efficiency daily dialysis (SLEDD).
• Discussion of factors influencing modality selection based on clinical scenarios and local expertise.

Main Results:

• ARF management strategies are currently heterogeneous.
• Multiple renal replacement therapy options exist, including IHD, CRRT, and SLEDD, each with unique benefits and drawbacks.
• No single modality has demonstrated superiority; individualized treatment selection is key.

Conclusions:

• Standardizing ARF treatment through initiatives like ADQI is crucial.
• Tailoring dialysis modality choice to patient needs and resource availability optimizes care.
• Developing evidence-based practice guidelines is recommended for consistent ARF management.